/HSCS
HSCS Stock - HeartSciences Inc.
Healthcare|Medical - DevicesNASDAQ
$2.36+7.76%
+$0.17 (+7.76%) • Dec 19
50
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.5
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.16
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+27.1%upside
Target: $3.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HSCS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.34 – $2.38
TARGET (TP)$3.00
STOP LOSS$2.17
RISK/REWARD1:3.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.59
52W High$6.47
52W Low$2.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4,350 | $18,600 | $5,150 | $14,373 | $25,604 |
| Gross Profit | $-125,485 | $-82,614 | $-24,561 | $-20,083 | $-18,672 |
| Gross Margin | -2884.7% | -444.2% | -476.9% | -139.7% | -72.9% |
| Operating Income | $-8,352,571 | $-6,305,770 | $-6,112,964 | $-4,709,399 | $-2,568,128 |
| Net Income | $-8,765,229 | $-6,605,208 | $-6,354,290 | $-4,828,260 | $-2,452,170 |
| Net Margin | -201499.5% | -35511.9% | -123384.3% | -33592.6% | -9577.3% |
| EPS | $-9.34 | $-18.74 | $-6173.88 | $-137.94 | $-77.89 |
Company Overview
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HSCSBeat Rate
36%
Last 14 quarters
Avg Surprise
-3854.8%
EPS vs Estimate
Beats / Misses
5/9
Last 12 quarters
Latest EPS
$-0.85
Q4 2025
EPS Surprise History
Q1 24
-4900.0%
$-3.00vs$-0.06
Q3 24
-437.4%
$-18.81vs$-3.50
Q3 24
-7.3%
$-2.64vs$-2.46
Q4 24
+1.3%
$-2.27vs$-2.30
Q1 25
-1.6%
$-2.57vs$-2.53
Q3 25
+25.1%
$-1.88vs$-2.51
Q3 25
+34.4%
$-1.58vs$-2.41
Q4 25
+5.6%
$-0.85vs$-0.90
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 12, 2026 | $-0.98 | — | — | — |
Q4 2025 | Dec 15, 2025 | $-0.90 | $-0.85 | +5.6% | ✓ BEAT |
Q3 2025 | Sep 11, 2025 | $-2.41 | $-1.58 | +34.4% | ✓ BEAT |
Q3 2025 | Jul 24, 2025 | $-2.51 | $-1.88 | +25.1% | ✓ BEAT |
Q1 2025 | Mar 13, 2025 | $-2.53 | $-2.57 | -1.6% | ✗ MISS |
Q4 2024 | Dec 16, 2024 | $-2.30 | $-2.27 | +1.3% | ✓ BEAT |
Q3 2024 | Sep 12, 2024 | $-2.46 | $-2.64 | -7.3% | ✗ MISS |
Q3 2024 | Jul 29, 2024 | $-3.50 | $-18.81 | -437.4% | ✗ MISS |
Q1 2024 | Mar 14, 2024 | $-0.06 | $-3.00 | -4900.0% | ✗ MISS |
Q4 2023 | Dec 14, 2023 | $-0.12 | $-16.00 | -13233.3% | ✗ MISS |
Q3 2023 | Sep 14, 2023 | $-0.14 | $-13.00 | -9185.7% | ✗ MISS |
Q3 2023 | Jul 18, 2023 | $-0.16 | $-16.00 | -9900.0% | ✗ MISS |
Q1 2023 | Mar 16, 2023 | $-0.16 | $-16.00 | -9900.0% | ✗ MISS |
Q4 2022 | Dec 15, 2022 | $-0.33 | $-22.00 | -6566.7% | ✗ MISS |
Q3 2022 | Sep 12, 2022 | $-28.00 | $-0.28 | +99.0% | ✓ BEAT |
Q3 2022 | Jul 29, 2022 | — | $-64.03 | — | — |
Q1 2022 | Jan 31, 2022 | — | $-37.27 | — | — |
Q4 2021 | Oct 31, 2021 | — | $-31.23 | — | — |
Q3 2021 | Jul 31, 2021 | — | $-15.14 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-25.70 | — | — |
Latest News
HSCS stock has given up its prior gain. HeartSciences shares were trading higher after the company reported better-than-expected Q2 EPS results.
➖ NeutralBenzinga•Dec 15, 2025, 10:21 PM
HeartSciences shares are trading higher after the company reported better-than-expected Q2 EPS results.
📈 PositiveBenzinga•Dec 15, 2025, 09:31 PM
CORRECTION: Heart Test Laboratories Q2 EPS $(0.85) Beats $(1.69) Estimate, Sales $2.419K Miss $50.000K Estimate
➖ NeutralBenzinga•Dec 15, 2025, 09:24 PM
Heart Test Laboratories Q2 EPS $(0.85) Beats $(1.69) Estimate, Sales $2.419M Beat $50.000K Estimate
📈 PositiveBenzinga•Dec 15, 2025, 09:20 PM
HeartSciences Submits MyoVista wavECG Device To FDA For 510(k) Premarket Clearance
📈 PositiveBenzinga•Dec 15, 2025, 01:52 PM
Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $9
📈 PositiveBenzinga•Oct 1, 2025, 10:27 AM
HeartSciences Q1 EPS $(1.58) Beats $(2.09) Estimate, Sales $1.900M
📈 PositiveBenzinga•Sep 11, 2025, 08:24 PM
Frequently Asked Questions about HSCS
What is HSCS's current stock price?
HeartSciences Inc. (HSCS) is currently trading at $2.36 per share. The stock has moved +7.76% today.
What is the analyst price target for HSCS?
The average analyst price target for HSCS is $3.00, based on 1 analyst.
What sector is HeartSciences Inc. in?
HeartSciences Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is HSCS's market cap?
HeartSciences Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does HSCS pay dividends?
No, HeartSciences Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMIX
Autonomix Medical, Inc. Common Stock
$0.63
Mkt Cap: $0.0B
BCLI
Brainstorm Cell Therapeutics Inc.
$0.56
Mkt Cap: $0.0B
BMRA
Biomerica, Inc.
$2.31
Mkt Cap: $0.0B
GBS
GBS Inc.
$0.47
Mkt Cap: $0.0B
IBO
Impact BioMedical Inc.
$0.65
Mkt Cap: $0.0B
MTNB
Matinas BioPharma Holdings, Inc.
$0.73
Mkt Cap: $0.0B
MYNZ
Mainz Biomed B.V.
$1.20
Mkt Cap: $0.0B
NRSN
NeuroSense Therapeutics Ltd.
$0.81
Mkt Cap: $0.0B
PAVM
PAVmed Inc.
$0.31
Mkt Cap: $0.0B
SSKN
STRATA Skin Sciences, Inc.
$1.19
Mkt Cap: $0.0B
Explore stocks similar to HSCS for comparison